Global Biomaterials Market
This comprehensive report provides segmented market valuations and forecasts along with detailed factor analysis and competitive scenarios.
- Study Reveals that the Global Biomaterials Market is estimated to reach a valuation of USD 348.4 Bn by 2028 at a CAGR of 15.90% from USD 106.5 Bn in 2020. The forecast window and analysis period can be customized.
The market valuation, forecast, and analysis are segmented by the following categories which too can be customized if required.
- Type: Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial.
- Application: Neurology, Cardiology, Orthopedics, Ophthalmology, Wound Care, Dental, Plastic Surgery, OPlastic Surgery, Others.
- By Region: North America, Europe, Asia Pacific, Middle East, Africa, and Latin America – Each Region Will Be Further Divided Into Major Countries As Required.
Companies presented in the report include – Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., Medtronic PLC, Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corporation.